Skip to main content

Elanco Animal Health Inc

corporate_fare Company Profile

Elanco Animal Health Inc

ELAN·NYSE·Life Sciences·CIK 0001739104

Elanco Animal Health Incorporated is a global leader in animal health, focused on innovating and delivering products and services to prevent and treat disease in farm animals and pets. The company partners with farmers, pet owners, veterinarians, and society to improve animal health. Elanco's diverse product portfolio is sold in more than 90 countries. Its products serve various animal species, primarily dogs and cats (referred to as pet health) and cattle, poultry, swine, and sheep (referred to as farm animal). The company aims to address critical health needs and increase access to health products and services for animals. For customers, Elanco provides science-based, scalable, and sustainable solutions to unlock economic value for producers and supports the professional wellness of veterinarians. The company also focuses on recruiting, retaining, and empowering its workforce. Furthermore, Elanco is committed to improving human health through animals, delivering reliable products, and safeguarding the food system, ensuring consumer and pet owner health and safety, and protecting the accessibility and availability of affordable animal protein.

Elanco Animal Health Inc (NYSE:ELAN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for ELAN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for ELAN spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • FDA Authorizes Elanco's CLiK Extra Spray to Combat Screwworm Outbreak
  • Elanco Q2 Earnings Crush Estimates, Raises Full-Year Outlook on Pet Health Boom
  • Elanco Q2 Revenue Jumps 10% to $1.37B, Raises Full-Year Guidance
  • Elanco Raises Full-Year Outlook on Strong Q2, Led by Pet Health and Innovation
  • Elanco Guides FY Revenue to $5.09B-$5.14B, In Line with Expectations

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.71B
Net Income
-$232M
Diluted EPS
-$0.47
Op. Cash Flow
$560M
Free Cash Flow
$284M
Gross Profit
$2.59B
Cash & Equivalents
$545M
Total Debt
$3.76B
Debt / Equity
0.57×
Net Margin
-4.9%
Shares Outstanding
496.98M sh
Source: 10-K · filed 2026-02-24 · accession 0001739104-26-000012
Browse all tickers starting with E →
$22.45 +0.03% today
52-week range · as of 2026-08-05 $13.75 – $27.72
Market cap
$11.2B
Volume
7.9M (1.2× avg)
3-mo avg 6.6M
Live data · 2026-09-20 02:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ELAN - Latest Insights

ELAN
Aug 07, 2026, 2:20 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $22.53
Real-time Price: $22.45 info
Change: -$0.080 (-0.36%) info
Market Cap: $11.202B info
ELAN
Aug 05, 2026, 12:57 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $26.38
Real-time Price: $22.45 info
Change: -$3.93 (-15%) info
Market Cap: $11.202B info
ELAN
Aug 05, 2026, 9:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $27.14
Real-time Price: $22.45 info
Change: -$4.69 (-17%) info
Market Cap: $11.202B info
ELAN
Aug 05, 2026, 6:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.80
Real-time Price: $22.45 info
Change: -$3.35 (-13%) info
Market Cap: $11.202B info
ELAN
Aug 05, 2026, 6:27 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $25.80
Real-time Price: $22.45 info
Change: -$3.35 (-13%) info
Market Cap: $11.202B info
ELAN
Jun 04, 2026, 1:47 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $24.94
Real-time Price: $22.45 info
Change: -$2.48 (-10%) info
Market Cap: $11.202B info
ELAN
Jun 04, 2026, 6:26 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $23.40
Real-time Price: $22.45 info
Change: -$0.950 (-4%) info
Market Cap: $11.202B info
ELAN
May 18, 2026, 7:27 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $19.84
Real-time Price: $22.45 info
Change: +$2.61 (+13%) info
Market Cap: $11.202B info
ELAN
May 06, 2026, 9:04 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.00
Real-time Price: $22.45 info
Change: -$1.55 (-6%) info
Market Cap: $11.202B info
ELAN
May 06, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.99
Real-time Price: $22.45 info
Change: -$0.540 (-2%) info
Market Cap: $11.202B info
ELAN
May 06, 2026, 6:27 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $22.99
Real-time Price: $22.45 info
Change: -$0.540 (-2%) info
Market Cap: $11.202B info
ELAN
Apr 27, 2026, 6:59 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $22.01
Real-time Price: $22.45 info
Change: +$0.440 (+2%) info
Market Cap: $11.202B info
ELAN
Apr 08, 2026, 10:07 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $23.85
Real-time Price: $22.45 info
Change: -$1.40 (-6%) info
Market Cap: $11.202B info
ELAN
Feb 24, 2026, 9:19 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $24.60
Real-time Price: $22.45 info
Change: -$2.15 (-9%) info
Market Cap: $11.202B info
ELAN
Feb 24, 2026, 6:28 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.61
Real-time Price: $22.45 info
Change: -$2.16 (-9%) info
Market Cap: $11.202B info
ELAN
Jan 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.55
Real-time Price: $22.45 info
Change: -$1.10 (-5%) info
Market Cap: $11.202B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets